A pharmaceutical composition for treating or preventing a papillomavirus infection or tumor, including, as the therapeutical agents, a polypeptide from an early region and a polypeptide from a late region of a papillomavirus, optionally combined with a polypeptide having immunostimulatory activity or a polypeptide from an early or late region of a papillomavirus and a polypeptide having immunostimulatory activity, or alternatively, a recombinant vector containing inserted DNA fragments coding for the above-mentioned polypeptide combinations.

 
Web www.patentalert.com

< Herpes simplex virus vector

> Methods and reagents for immunization which generate a CD8 T cell immune response

> Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof

~ 00585